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Background: The 2012 World Health Assembly set a target for Member States to reduce premature non-communicable
disease (NCD) mortality by 25% over the period 2010 to 2025. This reflected concerns about increasing NCD mortality
burdens among productive adults globally. This article first considers whether the WHO target of a 25% reduction in the
unconditional probability of dying between ages of 30 and 70 from NCDs (cardiovascular diseases, cancer, diabetes, or
chronic respiratory diseases) has already taken place in Sweden during an equivalent 15-year period. Secondly, it assesses
which population sub-groups have been more or less successful in contributing to overall changes in premature NCD
mortality in Sweden.
Methods: A retrospective dynamic cohort database was constructed from Swedish population registers in the Linnaeus
database, covering the entire population in the age range 30 to 69 years for the period 1991 to 2006, which was used
directly to measure reductions in premature NCD mortality using a life table method as specified by the WHO.
Multivariate Poisson regression models were used to assess the contributions of individual background factors to
decreases in premature NCD mortality.
Results: A total of 292,320 deaths occurred in the 30 to 69 year age group during the period 1991 to 2006, against
70,768,848 person-years registered. The crude all-cause mortality rate declined from 5.03 to 3.72 per 1,000 person-years,
a 26% reduction. Within this, the unconditional probability of dying between the ages of 30 and 70 from NCD causes
as defined by the WHO fell by 30.0%. Age was consistently the strongest determinant of NCD mortality. Background
determinants of NCD mortality changed significantly over the four time periods 1991–1994, 1995–1998, 1999–2002,
and 2003–2006.
Conclusions: Sweden, now at a late stage of epidemiological transition, has already exceeded the 25% premature
NCD mortality reduction target during an earlier 15-year period. This should be encouraging news for countries
currently implementing premature NCD mortality reduction programmes. Our findings suggest, however, that it
may be difficult for Sweden and other late-transition countries to reach the current 25 × 25 target, particularly
where substantial premature mortality reductions have already been achieved.
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In the 2012 session of the World Health Assembly
(WHA), Member States adopted a resolution calling for
a 25% reduction in premature non-communicable dis-
ease (NCD) mortality in the period 2010 to 2025 – the
so-called “25 × 25” target [1]. Approximately two-thirds
of all deaths worldwide are due to NCDs [2], and that is
not set to reduce as populations grow older and risks as-
sociated with other causes of mortality are controlled.
The major issue of concern is the proportion of NCD
mortality that occurs in younger age groups. The WHA
resolution has been widely misquoted with the omission
of the critical word ‘premature’, making the target imme-
diately impossible to achieve in any population where
life expectancy is increasing. Where the importance of
‘premature’ mortality has been acknowledged, it has
not always been clear how it should be defined [3]. A
definition became clear in the 2014 World Health
Organization (WHO) Global Status Report [4]: a 25%
relative reduction in the “unconditional probability of
dying between ages of 30 and 70 from cardiovascular dis-
eases, cancer, diabetes or chronic respiratory diseases”. It
has also been noted that the 25 × 25 target is intended to
apply to all Member States, rather than primarily those
from the developing world targeted by the Millennium
Development Goals [5].
The apparently simple concept of a common NCD
mortality target for all countries, irrespective of disease
patterns and health service status, is epidemiologically
complex. It is probably not to be expected that there
would be universally applicable strategies of equal effect-
iveness for all situations. Countries varied considerably
in terms of stages of epidemiological transition at the
2010 baseline for the 25 × 25 target, from those for
which NCD mortality, as yet, accounts for a relatively
small proportion of mortality, to those for which prema-
ture NCD mortality has been a longstanding issue of
concern [6].
Sweden is a country which has reached an advanced
stage of epidemiological transition, with high-quality
universal health service coverage and high life expect-
ancy. At the start of the WHO 25 × 25 target period in
2010, life expectancy in Sweden was already 83.5 years
for women and 79.5 years for men [7]. Whether or not
it will be possible for Sweden to achieve the 25 × 25 pre-
mature NCD mortality reduction goal set by the inter-
national community is, as yet, a matter for conjecture.
However, because of the highly functional individual
data registers that are routinely maintained in Sweden,
it is possible to consider whether an equivalent target
might have been achieved in an earlier period. We
believe this to be a particularly relevant question, be-
cause a number of other countries will be tackling the
25 × 25 premature NCD mortality target at stages ofepidemiological transition corresponding to those which
have already been encountered in Sweden. There may
therefore be lessons to be learnt from the Swedish ex-
perience in terms of possible progress elsewhere.
Our aim in this paper is to assess whether a postulated
target of a 25% reduction in the unconditional probability
of dying between ages of 30 and 70 from cardiovascular
diseases, cancer, diabetes, or chronic respiratory diseases
during an earlier equivalent time period approximately a
generation earlier (1991 to 2006) was achieved in Sweden,
using individual national data. Secondary objectives are to
assess which population sub-groups were more or less
successful in contributing to changes in premature NCD
mortality, drawing lessons of global relevance for coun-
tries aiming to achieve 25% reductions in premature NCD
mortality from 2010 to 2025.
Methods
The WHO materials specifying the 25 × 25 target do not
specify details of the timeframe as clearly as might be
expected. Since mortality rates can only be measured for
a period of time (for example, over a calendar year) ra-
ther than instantaneously, we have taken the view that
the endpoints for the 25 × 25 target are mortality rates
during 2025. Similarly, if the baseline is 2010, then the
starting points have to be mortality rates during 2010,
and therefore the overall duration from 2010 to 2025
over which changes are measured can be regarded as
the 15-year period between the midpoints of those
years. For the earlier period for which Swedish data were
analysed, we considered a directly equivalent 15-year
period from 1991 to 2006, for which the relevant data
were available.
We used retrospective cohort data from Swedish
population registers, covering the national population
within the age range 30 to 69 years, including records of
cause-specific mortality, for the period 1991 to 2006, to
construct a dynamic cohort. Individual background char-
acteristics were recorded at the time of entry to the
cohort. The data, obtained from the Linnaeus database,
were compiled by linking individual national registers
from the National Board for Health and Welfare and
from Statistics Sweden [8]. The dataset included individ-
ual status on socioeconomics, work, family, and resi-
dence from Statistics Sweden and sex, age, and cause of
death from the National Board for Health and Welfare.
Causes of death had been coded according to the Inter-
national Classification of Diseases 9th and 10th revisions
(ICD-9 and ICD-10) based on the ICD codes defined by
the WHO [4], classifying NCD deaths into four groups
by ICD-10 codes: cardiovascular disease (I00-I99), cancer
(C00-C97), diabetes (E10-E14), and chronic respiratory
disease (J30-J98). The following potential determinants of
mortality were considered: sex (male or female), marital
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attainment (primary, lower secondary, upper secondary,
tertiary, or unknown), employment status (full-time with
high, medium, or low income, part-time, or not employed),
and migration status (in-migrant or Swedish-born).
Statistical analysis
Mortality was analysed in terms of the unconditional
probability of dying between ages 30 and 70 from the
four NCD groups, calculating unconditional probability
using a life table method as specified by the WHO [4].
Mortality rate ratios with 95% confidence intervals (CIs)
were calculated from Poisson regression models, using
person-years of residence as exposure time. Multivariate
Poisson regression analyses were used to assess which
population sub-groups were more or less successful in
contributing to decreases in premature NCD mortality.
The Poisson models included adjustment for age in de-
cades (30–39, 40–49, 50–59, 60–69) and for calendar
time in four-year periods (1991–1994, 1995–1998,
1999–2002, 2003–2006). Stata 12 software was used for
analyses. Because of the very large size of the dataset,
hypothesis testing leading to P values was not particu-
larly helpful and comparisons were primarily assessed on
the basis of 95% CIs.
Results
Overall, the mid-year population of Sweden increased
from 8,668,066 in 1991 to 9,080,505 in 2006. People
aged 30 to 69 years comprised 48.4% of the 1991 popu-
lation, and increased to 51.6% of the 2006 population, as
the population proportion of younger people decreased.
A total of 292,320 deaths occurred in the 30 to 69 year
age group during the period 1991 to 2006, against
70,768,848 individually registered person-years for the
same age range, corresponding to a crude mortality rate
of 4.13 per 1,000 person-years. Table 1 shows how this
overall mortality was distributed among various cause of
death groups and background factors. Out of the total
deaths, 215,185 (73.6%) met the WHO definition of pre-
mature NCD deaths, comprising cardiovascular (41.8%),
cancer (51.7%), diabetes (2.6%), and chronic respiratory
diseases (3.9%).
From 1991 to 2006, the unconditional probability of
death from all causes from 30 to 70 years in Sweden fell
by 26.6%. Within this, the unconditional probability of
premature death from NCD according to the WHO
definition fell by 30.0%. Therefore, the postulated target
of a 25% reduction was clearly met. Cardiovascular mor-
tality changes showed the largest reduction (48.3%), as
shown in Figure 1. Cancer rates, as the largest of the
four components of NCD mortality, declined more mod-
estly (15.5%). Mortality attributed to diabetes accounted
for a small proportion of overall mortality and did notcontribute appreciably to overall reductions, having re-
duced by only 1.5%. Chronic respiratory disease was
also a minor contributor to overall mortality, but re-
duced by 19.7%. The rate of reduction in premature
NCD mortality declined over the overall 1991 to 2006
period; 54.2% of the overall reduction occurred in the
first half of the period.
Since it is clear that many of the factors examined were
inter-related – particularly age in relation to marital, edu-
cational, and employment status – Table 2 shows an ad-
justed multivariate Poisson regression model of mortality
rate ratios for the same causes of death and background
factors as shown in Table 1. After adjustment, age group
was the major determinant of NCD mortality.
Similar adjusted multivariate Poisson regression models
were examined for each of the four time periods during
the overall 1991–2006 period. Figure 2 shows NCD mor-
tality rate ratios and 95% CIs and background factor, with
the same reference categories as in Table 2 (female, 30 to
39 years, partnered, tertiary education, full-time employ-
ment with high income, in-migrant). Age group, and to a
lesser extent education, became increasingly strong deter-
minants of NCD mortality as time passed. Employment,
sex, marital status, and migration status became less
strongly associated with NCD mortality as time passed.
Excess mortality among males persisted over the four time
periods. The in-migrant group experienced a mortality ad-
vantage in earlier periods compared with those born in
Sweden, but this reduced to a nil difference in the final
time period.
Discussion
Our results show that Sweden has already met the pos-
tulated target of a 25% reduction in premature NCD
mortality over a 15-year period. We discuss our findings
below, firstly, in terms of interpreting the Swedish ex-
perience; secondly, examining the implications for the
25 × 25 target in Sweden (and other countries already at
a late stage of epidemiological transition by 2010); and
thirdly, considering strategic implications that may help
countries at earlier stages of epidemiological transition
to achieve the 25 × 25 target.
The Swedish experience of achieving a 25% reduction in
premature NCD mortality over 15 years
Although Sweden achieved a 25% reduction in premature
NCD mortality during the period 1991 to 2006, this was
not done against any specific international target, but
simply as part of continuing improvements in public
health in Sweden, and against a background of relatively
good socio-economic conditions and biomedical advances.
Nevertheless, it clearly demonstrates that this rate of
reduction in premature NCD mortality in countries at rela-
tively late stages of epidemiological transition is possible.
Table 1 Crude mortality rates per 1,000 person-years for the 30 to 69 year age group in the Swedish population during
1991 to 2006, by causes of death and background factors, for 292,320 deaths occurring over 70,768,842 person-years
All causes Non-communicable disease causes Other
causesCardiovascular Cancer Diabetes Chronic respiratory All
Overall 4.13 1.27 1.57 0.08 0.12 3.04 1.09
Sex
Female 3.14 0.70 1.57 0.05 0.11 2.44 0.70
Male 5.10 1.84 1.58 0.10 0.12 3.64 1.47
Age group
30–39 years 0.74 0.08 0.15 0.01 0.01 0.26 0.49
40–49 years 1.79 0.36 0.57 0.03 0.02 0.98 0.80
50–59 years 4.49 1.23 1.81 0.08 0.09 3.22 1.27
60–69 years 11.90 4.35 4.75 0.22 0.45 9.78 2.13
Time period
2003–2006 3.76 0.99 1.53 0.08 0.11 2.71 1.04
1999–2002 3.89 1.15 1.51 0.07 0.12 2.86 1.03
1995–1998 4.18 1.34 1.57 0.08 0.12 3.11 1.08
1991–1994 4.75 1.65 1.69 0.08 0.13 3.54 1.21
Marital status
Partnered 3.97 1.23 1.79 0.06 0.10 3.19 0.78
Single 2.98 0.87 0.79 0.07 0.07 1.80 1.18
Widowed/divorced 8.60 2.76 2.97 0.17 0.35 6.24 2.36
Education level
Tertiary 2.38 0.59 1.13 0.03 0.04 1.78 0.60
Upper secondary 3.29 0.93 1.28 0.06 0.08 2.35 0.93
Lower secondary 3.09 0.77 1.05 0.06 0.08 1.96 1.13
Primary 9.55 3.52 3.46 0.20 0.35 7.53 2.02
Unknown 3.93 1.13 1.11 0.08 0.11 2.44 1.49
Employment status
Full-time – high income 3.07 0.92 1.42 0.03 0.04 2.42 0.65
Full-time – mid income 3.08 0.89 1.36 0.04 0.06 2.36 0.72
Full-time – low income 3.41 0.91 1.42 0.06 0.09 2.49 0.92
Part-time employment 2.79 0.67 0.97 0.06 0.06 1.76 1.03
Not employed 10.42 3.80 2.95 0.26 0.44 7.45 2.97
Migration status
In-migrant 3.23 0.92 1.15 0.06 0.08 2.20 1.03
Swedish-born 4.29 1.33 1.65 0.08 0.12 3.19 1.10
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Swedish population registers provides an unparalleled
opportunity to examine how the 25% reduction in pre-
mature NCD mortality came about. Figure 2 shows that
there were bigger relative reductions in premature NCD
mortality over time for the younger age groups. Mortal-
ity rate differences between various sub-groups were
very predictable; being partnered, more educated, and
employed in higher income groups were all protective
against premature NCD death, even though each groupunderwent its own mortality transition over time. Being
male carried a higher risk than most background factors
for premature NCD death. These mortality inequalities
are generally consistent with those reported from a
large-scale European study [9].
The ‘not employed’ and ‘Swedish-born’ categories within
the analysis need special interpretation. Those ‘not
employed’ included ‘retired’ people (mostly in the 60 to
69 year age group) as well as those who were unemployed
for other reasons such as sickness. Consequently, there
Figure 1 Overall unconditional probabilities of dying between the ages of 30 and 70 in Sweden from 1991 to 2006, showing
non-communicable disease mortality split between cardiovascular, cancer, diabetes and chronic respiratory causes, and all other
causes of death.
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not being employed, even after adjustment for age. The
in-migrant group experienced a considerable mortality ad-
vantage compared with those born in Sweden in earlier
periods, but this reduced to a nil difference in the final
time period. This may be consistent with a ‘healthy mi-
grant’ effect (whereby self-selection means that migrants
might be less likely to have NCDs on arrival), but this dif-
ference seemed to diminish over time [10].
Causes of NCDs are multi-factorial, and associated with
social determinants of health, including physical, environ-
mental, biological, behavioural, and socio-economic fac-
tors. Latency periods between NCD risk exposures and
mortality outcomes are also complex. In Sweden, the
current prevalence of daily smoking among men is lower
than among women and also low compared with other
European countries [11]. As smoking has declined signifi-
cantly in recent decades, alcohol consumption has in-
creased [12]. The proportion of overweight and obese
people has also increased, particularly among lower edu-
cated groups [13]. Past risk exposures will have driven our
mortality findings during the 1991 to 2006 period, and,
combined with more recent exposures, will contribute to
determining future NCD mortality in Sweden.
We were unable to consider NCD risk factors such as
obesity, smoking, alcohol consumption, and physical ac-
tivity on an individual basis in the Swedish dataset, and
hence are unable to conclude on the potential contribu-
tions of NCD risk-reduction strategies to the premature
NCD mortality reductions observed. Further work is be-
ing conducted to examine how major NCD risk factorsmay have influenced premature NCD mortality reduc-
tions in an area of northern Sweden, in a population for
which detailed individual risk factor data are available.
Modelled findings have suggested that reducing NCD
risks can contribute considerably to mortality reductions
in the context of the 25 × 25 target [14]. Risk reduction
is also, therefore, likely to be an important component
of national strategies aimed at the target.
Implications for the 25 × 25 target in Sweden and other
late-transition countries
In real terms for the Swedish population, the reductions
in premature NCD mortality achieved from 1991 to
2006 corresponded to about 3,000 premature deaths
averted annually. The 25% target reduction was achieved
against the background of continuing population ageing
in Sweden, though younger age groups benefited to a
greater extent from mortality reductions. This suggests
that the WHO 25 × 25 target is robustly formulated in
considering the unconditional probability of dying, ra-
ther than taking any other more complex endpoint.
However, having achieved a 25% reduction in a previous
generation does not necessarily mean that Sweden can
achieve it again for the 2010 to 2025 period, as defined
in the WHO 25 × 25 target. It was clear from our ana-
lyses that most of the deaths averted in Sweden were as-
sociated with reductions in premature cardiovascular
mortality, whilst the other major component of prema-
ture NCD deaths, cancer mortality, reduced by a much
smaller proportion. Furthermore, the overall rate of re-
duction in premature NCD mortality fell steadily during
Table 2 Adjusted mortality rate ratios (95% confidence intervals) by causes of death and background factors, for the
30 to 69 year age group in Sweden during 1991 to 2006, using a Poisson regression model
All causes Non-communicable disease causes Other causes
Cardiovascular Cancer Diabetes Chronic respiratory All
Sex (reference: Female)
Male 1.93 (1.91–1.94) 3.18 (3.14–3.23) 1.14 (1.12–1.15) 2.38 (2.25–2.52) 1.38 (1.32–1.44) 1.76 (1.74–1.78) 2.48 (2.44–2.52)
Age group (reference: 30–39 years)
40–49 years 2.99 (2.93–3.05) 5.39 (5.11–5.69) 4.02 (3.86–4.19) 3.61 (3.14–4.16) 3.68 (3.04–4.45) 4.50 (4.30–4.58) 2.31 (2.25–2.37)
50–59 years 7.88 (7.74–8.03) 19.3 (18.3–20.3) 12.8 (12.3–13.3) 9.00 (7.87–10.3) 17.3 (14.5–20.5) 15.1 (14.2–15.1) 4.04 (3.94–4.15)
60–69 years 17.0 (16.7–17.3) 52.5 (49.9–55.3) 29.9 (28.8–31.1) 17.5 (15.3–20.1) 57.8 (48.7–68.6) 37.8 (34.4–36.5) 5.22 (5.08–5.37)
Time period (reference: 2003–2006)
1999–2002 1.06 (1.05–1.07) 1.18 (1.15–1.20) 1.01 (1.00–1.03) 0.94 (0.87–1.01) 1.00 (0.94–1.06) 1.07 (1.06–1.08) 1.04 (1.02–1.07)
1995–1998 1.07 (1.06–1.08) 1.23 (1.21–1.26) 1.02 (1.01–1.04) 0.84 (0.78–0.91) 0.81 (0.76–0.86) 1.09 (1.07–1.10) 1.05 (1.03–1.07)
1991-1994 1.01 (1.00–1.02) 1.17 (1.15–1.20) 0.99 (0.97–1.00) 0.63 (0.58–0.68) 0.61 (0.56–0.64) 1.03 (1.02–1.04) 1.01 (0.99–1.03)
Marital status (reference: partnered)
Single 1.58 (1.57–1.60) 1.68 (1.65–1.70) 1.13 (1.11–1.14) 2.03 (1.90–2.18) 1.88 (1.78–2.00) 1.40 (1.38–1.41) 2.19 (2.15–2.23)
Widowed/divorced 1.68 (1.67–1.70) 1.71 (1.68–1.74) 1.28 (1.26–1.30) 1.90 (1.77–2.03) 2.39 (2.28–2.51) 1.50 (1.48–1.51) 2.45 (2.41–2.50)
Education level (reference: tertiary)
Upper secondary 1.23 (1.21–1.24) 1.37 (1.34–1.40) 1.12 (1.10–1.42) 1.53 (1.38–1.70) 1.71 (1.52–2.08) 1.21 (1.19–1.23) 1.28 (1.25–1.31)
Lower secondary 1.37 (1.35–1.39) 1.50 (1.45–1.55) 1.14 (1.12–1.17) 1.74 (1.53–1.97) 1.99 (1.78–2.22) 1.28 (1.25–1.30) 1.55 (1.50–1.59)
Primary 1.40 (1.38–1.42) 1.68 (1.64–1.72) 1.23 (1.20–1.25) 1.99 (1.79–2.21) 2.11 (1.93–2.32) 1.40 (1.38–1.42) 1.38 (1.34–1.41)
Unknown 1.31 (1.27–1.34) 1.43 (1.36–1.50) 1.21 (1.15–1.26) 1.39 (1.16–1.68) 1.77 (1.52–2.08) 1.26 (1.23–1.30) 1.35 (1.29–1.41)
Employment status (reference: full-time – high income)
Full-time – mid income 1.24 (1.22–1.26) 1.26 (1.23–1.30) 1.16 (1.13–1.19) 1.51 (1.19–1.75) 1.49 (1.31–1.69) 1.23 (1.21–1.26) 1.26 (1.22–1.30)
Full-time – low income 1.80 (1.77–1.83) 1.86 (1.81–1.92) 1.42 (1.38–1.46) 3.25 (2.79–3.78) 2.53 (2.22–2.87) 1.68 (1.65–1.72) 2.21 (2.13–2.28)
Part-time employment 1.73 (1.69–1.78) 1.70 (1.62–1.78) 1.30 (1.25–1.35) 3.08 (2.52–3.76) 2.19 (1.83–2.63) 1.53 (1.48–1.58) 2.35 (2.25–2.46)
Not employed 3.31 (3.26–3.37) 3.88 (3.76–4.00) 1.83 (1.78–1.88) 8.46 (7.28–9.84) 7.42 (6.53–8.43) 2.86 (2.81–2.92) 5.04 (4.87–5.22)
Migration status (reference: in-migrant)
Swedish-born 1.42 (1.40–1.44) 1.49 (1.45–1.52) 1.39 (1.36–1.42) 1.73 (1.58–1.90) 1.87 (1.73–2.02) 1.46 (1.44–1.48) 1.33 (1.30–1.36)
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be achievable in Sweden during 2010 to 2025.
There is therefore a distinct possibility that Sweden,
along with other countries already at a late stage of epi-
demiological transition in 2010, will not go on to achieve
the 25 × 25 target, partly because of their earlier successes.
In purely demographic terms, there is a potentially per-
verse effect whereby initial mortality reductions across the
30 to 69 age group may lead to increasingly equal num-
bers of people in each year of age, hence increasing the
proportion of older people within the 30 to 69 age group
and so making further mortality reductions less possible.
In public health terms, depending what strategies are used
to facilitate premature NCD mortality reduction, there
may also be diminishing returns over time, after higher-
risk individual deaths are initially averted.
Thus, although the WHO 25 × 25 target was aimed at
all countries irrespective of their stage of epidemiological
transition, it is likely that the outcomes in 2025 will not beindependent of countries’ 2010 transitional status. It was
also clear from the Swedish case that premature NCD
mortality accounted for around three-quarters of all mor-
tality in the 30 to 69 year age group, and so any effective
overall mortality reduction in that age group has to be
predicated on reducing the NCD component. This is likely
to be the case for all countries where external and infec-
tious causes of death have already been relatively well
controlled in the 30 to 69 year age group. We suggest that
NCD management interventions targeted at the upper
range of the premature age group might be the most
effective way for countries to reach the 25 × 25 target,
although there may be more long-term benefits from
NCD risk factor interventions among younger adults.
Strategic implications for the 25 × 25 target in countries
at earlier stages of transition
Unsurprisingly, the overwhelming burden of premature
NCD mortality in Sweden occurred among older men,
Figure 2 Adjusted mortality rate ratios and 95% confidence intervals for premature non-communicable disease mortality for the 30 to
69 year age group in Sweden by time period and background factors, using Poisson regression models for each time period.
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where. Data from the INDEPTH Network suggested that,
for Africa and Asia, where most deaths are not routinely
documented, a little under half of adult NCD deaths oc-
curred under 65 years of age, with population-based rates
in that age group being broadly similar across Africa and
Asia, as well as similar to the rates in Sweden described
herein [15]. Since the majority of the world’s population
lives in low- and middle-income countries, which are gen-
erally at various earlier stages of epidemiological transition
than Sweden, it will be important to achieve better
measurement and understanding of NCD mortality pat-
terns in such locations in assessing progress towards the
25 × 25 target. Premature NCD mortality in different
settings may account for variable proportions of overall
mortality, depending on patterns of non-NCD mortality
and age-sex population profiles, but there appears to
be greater consistency than might be supposed in
population-based rates of premature NCD mortality. In
Sweden, higher levels of education and income were
generally protective factors, and men carried a higher
mortality burden, so countries aiming at the 25 × 25target may well want to develop strategies that target
lower socio-economic groups of middle-aged men. The
apparently high premature NCD mortality associated
with not being employed in Sweden is probably inevit-
able, and most societies will include sub-groups disad-
vantaged by life-long medical conditions and other
factors that apparently lead to a higher mortality risk.
The pattern of mortality in Sweden among in-migrants
is interesting in that there was no suggestion from our
findings that migrants constituted a group needing spe-
cial attention in terms of premature NCD mortality risk
reduction strategies. This may also hold true elsewhere,
because of similar healthy migrant effects.
A global consideration of premature mortality bur-
dens, though necessarily dependent on much scantier
data than those available for Sweden, concluded that
there were substantial reductions in mortality over the
period 1970 to 2010 and was reasonably optimistic about
the prospects for further global reductions [16]. This re-
view, however, noted that countries would need to set
different priorities depending on existing mortality pat-
terns in order to achieve maximum benefits.
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It is impossible to robustly generalise from the Swedish
experience of successful premature NCD mortality re-
duction, over a period a generation earlier in calendar
time than the WHO 25 × 25 target, but nevertheless oc-
curring during a late stage of epidemiological transition.
Our findings suggest that it may be difficult for Sweden
and other late-transition countries to reach the 25 × 25
target during the current target period, particularly in
countries where substantial premature mortality reduc-
tions have already been achieved. The Swedish case sug-
gests that, unless there are further major improvements
in cancer incidence or survival, it will be hard to reduce
premature NCD mortality much further. On the other
hand, Sweden has shown that the 25% premature NCD
mortality reduction target clearly can be achieved over a
15-year period, which should be encouraging news for
countries currently implementing premature NCD mor-
tality reduction programmes. Good civil registration and
health information systems as implemented in Sweden,
including robust cause of death assignment [17], will be
essential to track progress towards the WHO 25 × 25
target in other countries if there are to be clear assess-
ments of premature NCD mortality reductions globally
in 2025.Abbreviations
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